Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer

BACKGROUND AND PURPOSE To determine if there are differences between dose to pelvic bone marrow (PBM) using intensity modulated radiotherapy (IMRT) under UK guidance versus conformal radiotherapy (CRT) per ACT II protocol and if differences translate to rates of early haematological adverse events grade 3 or greater (HT3+). METHODS AND MATERIALS Two… CONTINUE READING